Literature DB >> 1563710

Expression of mutant p53 gene in squamous carcinoma arising in patients with recessive dystrophic epidermolysis bullosa.

S D Slater1, J A McGrath, C Hobbs, R A Eady, P H McKee.   

Abstract

Epidermolysis bullosa, a rare genodermatosis, is characterized by increased skin fragility manifest as blistering and sometimes accompanied by scarring. The latter is particularly severe in the recessive dystrophic variant and may be complicated by the development of squamous carcinoma in up to 30% of patients. We have studied 23 such tumours in six patients with this variant, with an anti-serum to p53 protein. Twenty-six per cent of the squamous carcinomas labelled positively for mutant-type p53 protein. This low figure, however, reflects the large number of well-differentiated tumours in this series, where 14 out of 15 were negative. In the moderate to poorly differentiated examples the positivity rate was 63%. Of the three patients in the latter category, one has died from disseminated tumour and another has widespread metastases. The findings support the hypothesis that mutant p53 protein expression correlates with poorer tumour differentiation. They also suggest a possible correlation between p53 protein expression and tumour behaviour.

Entities:  

Mesh:

Year:  1992        PMID: 1563710     DOI: 10.1111/j.1365-2559.1992.tb00962.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

1.  No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma.

Authors:  Karin J Purdie; Celine Pourreyron; Hiva Fassihi; Rodrigo Cepeda-Valdes; John W Frew; Andreas Volz; Sönke J Weissenborn; Herbert Pfister; Charlotte M Proby; Leena Bruckner-Tuderman; Dedee F Murrell; Julio C Salas-Alanis; John A McGrath; Irene M Leigh; Catherine A Harwood; Andrew P South
Journal:  J Invest Dermatol       Date:  2010-08-26       Impact factor: 8.551

2.  The eye in epidermolysis bullosa.

Authors:  L Tong; P R Hodgkins; J Denyer; D Brosnahan; J Harper; I Russell-Eggitt; D S Taylor; D Atherton
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

Review 3.  The extracellular matrix modulates the hallmarks of cancer.

Authors:  Michael W Pickup; Janna K Mouw; Valerie M Weaver
Journal:  EMBO Rep       Date:  2014-11-08       Impact factor: 8.807

4.  Immunohistochemical detection of the p53 oncoprotein in tumours of melanocytic origin.

Authors:  M Yamamoto; H Takahashi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity.

Authors:  Lydia A Hepburn; Angela McHugh; Kenneth Fernandes; Garry Boag; Charlotte M Proby; Irene M Leigh; Mark K Saville
Journal:  Oncotarget       Date:  2018-05-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.